CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.2.1.List of key players profiled in the report
1.3.Research methodology
1.3.1.Primary research
1.3.2.Secondary research
1.3.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.1.1.Top investment pockets
3.1.2.Top winning strategies
3.2.Key forces shaping veterinary medicines industry/Market
3.3.Market share analysis
3.4.Market dynamics
3.4.1.Drivers
3.4.1.1.Prevalence of cancer
3.4.1.2.Increase in adoption of cell culture technique
3.4.1.3.Increase in research funding
3.4.2.Restraints
3.4.2.1.High capital investment
3.4.2.2.Lack of infrastructure for cell-based research
3.4.3.Opportunity
3.4.3.1.Expected rise in demand for advanced technologies
3.4.4.Impact Analyses
3.5.Impact Analysis of COVID-19 on Cell Culture Market
CHAPTER 4:CELL CULTURE MARKET, BY PRODUCT
4.1.Overview
4.1.1.Market size and forecast
4.2.Instrument
4.2.1.Key findings and opportunity
4.2.2.Market size and forecast, by region
4.2.3.Market analysis by country
4.2.3.1.Bioreactors
4.2.3.2.Cell Culture Vessels
4.2.3.3.Cell Culture Storage Equipment
4.2.3.4.Cell Culture Supporting Instruments
4.3.Consumables
4.3.1.Key findings and opportunity
4.3.2.Market size and forecast, by region
4.3.3.Market analysis by country
4.3.3.1.Sera
4.3.3.2.Media
4.3.3.3.Reagents
4.3.3.4.Bioreactor Accessories
CHAPTER 5:CELL CULTURE MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast
5.2.Stem Cell Technology
5.2.1.Market size and forecast, by region
5.2.2.Market analysis by country
5.3.Cancer Research
5.3.1.Market size and forecast, by region
5.3.2.Market analysis by country
5.4.Drug Screening & Development
5.4.1.Market size and forecast, by region
5.4.2.Market analysis by country
5.5.Tissue Engineering & Regenerative Medicine
5.5.1.Market size and forecast, by region
5.5.2.Market analysis by country
5.6.Others
5.6.1.Market size and forecast, by region
5.6.2.Market analysis by country
CHAPTER 6:CELL CULTURE MARKET, BY END USER
6.1.Overview
6.1.1.Market size and forecast
6.2.Research Institutes
6.2.1.Market size and forecast, by region
6.2.2.Market analysis by country
6.3.Pharmaceutical & Biotechnology Companies
6.3.1.Market size and forecast, by region
6.3.2.Market analysis by country
6.4.Others
6.4.1.Market size and forecast, by region
6.4.2.Market analysis by country
CHAPTER 7:CELL CULTURE MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends and opportunities
7.2.2.North America cell culture market, by country
7.2.2.1.U.S. cell culture market, by product type
7.2.2.2.U.S. cell culture market, by application
7.2.2.3.U.S. cell culture market, by end user
7.2.2.4.Canada cell culture market, by product type
7.2.2.5.Canada cell culture market, by application
7.2.2.6.Canada cell culture market, by end user
7.2.2.7.Mexico cell culture market, by product type
7.2.2.8.Mexico cell culture market, by application
7.2.2.9.Mexico cell culture market, by end user
7.2.3.North America cell culture market, by product type
7.2.4.North America cell culture market, by application
7.2.5.North America cell culture market, by end user
7.3.Europe
7.3.1.Key market trends and opportunities
7.3.2.Europe cell culture market, by country
7.3.2.1.Germany cell culture market, by product type
7.3.2.2.Germany cell culture market, by application
7.3.2.3.Germany cell culture market, by end user
7.3.2.4.France cell culture market, by product type
7.3.2.5.France cell culture market, by application
7.3.2.6.France cell culture market, by end user
7.3.2.7.UK cell culture market, by product type
7.3.2.8.UK cell culture market, by application
7.3.2.9.UK cell culture market, by end user
7.3.2.10.Italy cell culture market, by product type
7.3.2.11.Italy cell culture market, by application
7.3.2.12.Italy cell culture market, by end user
7.3.2.13.Spain cell culture market, by product type
7.3.2.14.Spain cell culture market, by application
7.3.2.15.Spain cell culture market, by end user
7.3.2.16.Rest of Europe cell culture market, by product type
7.3.2.17.Rest of Europe cell culture market, by application
7.3.2.18.Rest of Europe cell culture market, by end user
7.3.3.Europe cell culture market, by product type
7.3.4.Europe cell culture market, by application
7.3.5.Europe cell culture market, by end user
7.4.Asia-Pacific
7.4.1.Key market trends and opportunities
7.4.2.Asia-Pacific cell culture market, by country
7.4.2.1.China cell culture market, by product type
7.4.2.2.China cell culture market, by application
7.4.2.3.China cell culture market, by end user
7.4.2.4.Japan cell culture market, by product type
7.4.2.5.Japan cell culture market, by application
7.4.2.6.Japan cell culture market, by end user
7.4.2.7.Australia cell culture market, by product type
7.4.2.8.Australia cell culture market, by application
7.4.2.9.Australia cell culture market, by end user
7.4.2.10.India cell culture market, by product type
7.4.2.11.India cell culture market, by application
7.4.2.12.India cell culture market, by end user
7.4.2.13.South Korea cell culture market, by product type
7.4.2.14.South Korea cell culture market, by application
7.4.2.15.South Korea cell culture market, by end user
7.4.2.16.Rest of Asia-Pacific cell culture market, by product type
7.4.2.17.Rest of Asia-Pacific cell culture market, by application
7.4.2.18.Rest of Asia-Pacific cell culture market, by end user
7.4.3.Asia-Pacific cell culture market, by product type
7.4.4.Asia-Pacific cell culture market, by application
7.4.5.Asia-Pacific cell culture market, by end user
7.5.LAMEA
7.5.1.Key market trends and opportunities
7.5.2.LAMEA cell culture market, by country
7.5.2.1.Brazil cell culture market, by product type
7.5.2.2.Brazil cell culture market, by application
7.5.2.3.Brazil cell culture market, by end user
7.5.2.4.Saudi Arabia cell culture market, by product type
7.5.2.5.Saudi Arabia cell culture market, by application
7.5.2.6.Saudi Arabia cell culture market, by end user
7.5.2.7.South Africa cell culture market, by product type
7.5.2.8.South Africa cell culture market, by application
7.5.2.9.South Africa cell culture market, by end user
7.5.2.10.Rest of LAMEA cell culture market, by product type
7.5.2.11.Rest of LAMEA cell culture market, by application
7.5.2.12.Rest of LAMEA cell culture market, by end user
7.5.3.LAMEA cell culture market, by product type
7.5.4.LAMEA cell culture market, by application
7.5.5.LAMEA cell culture market, by end user
CHAPTER 8:COMPANY PROFILES
8.1.BECTON, DICKINSON AND COMPANY
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.2.CORNING INCORPORATED
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance
8.2.6.Key strategic moves and developments
8.3.DANHER CORPORATION
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.4.EPPENDORF AG
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance
8.5.HIMEDIA LABORATORIES
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.6.LONZA GROUP LTD
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Operating product portfolio
8.6.5.Business performance
8.6.6.Key strategic moves and developments
8.7.MERCK KGAA
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.7.6.Key strategic moves and developments
8.8.PROMOCELL GmbH
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating product segments
8.8.4.Product portfolio
8.9.SARTORIUS AG
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.9.6.Key strategic moves and developments
8.10.THERMO FISHER SCIENTIFIC, INC.
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance
8.10.6.Key strategic moves and developments
TABLE 01.CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 02.INSTRUMENTS CELL CULTURE MARKET BY REGION 2019-2027, ($MILLION)
TABLE 03.CONSUMABLES CELL CULTURE MARKET BY REGION2019-2027, ($MILLION)
TABLE 04.CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 05.CELL CULTURE MARKET FOR STEM CELL TECHNOLOGY, BY REGION 2019–2027($MILLION)
TABLE 06.CELL CULTURE MARKET FOR CANCER RESEARCH, BY REGION 2019–2027 ($MILLION)
TABLE 07.CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY REGION 2019–2027 ($MILLION)
TABLE 08.CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION
2019–2027 ($MILLION)
TABLE 09.CELL CULTURE MARKET FOR OTHERS, BY REGION 2019–2027 ($MILLION)
TABLE 10.CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 11.CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY REGION 2019–2027($MILLION)
TABLE 12.CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION 2019–2027 ($MILLION)
TABLE 13.CELL CULTURE MARKET FOR OTHERS, BY REGION 2019–2027 ($MILLION)
TABLE 14.CELL CULTURE MARKET REVENUE, BY REGION, 2019–2027($MILLION)
TABLE 15.NORTH AMERICA CELL CULTURE MARKET, BY COUNTRY, 2019–2027($MILLION)
TABLE 16.U.S. CELL CULTURE MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 17.U.S. CELL CULTURE MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 18.U.S. CELL CULTURE MARKET, BY END USER, 2019–2027($MILLION)
TABLE 19.CANADA CELL CULTURE MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 20.CANADA CELL CULTURE MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 21.CANADA CELL CULTURE MARKET, BY END USER, 2019–2027($MILLION)
TABLE 22.MEXICO CELL CULTURE MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 23.MEXICO CELL CULTURE MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 24.MEXICO CELL CULTURE MARKET, BY END USER, 2019–2027($MILLION)
TABLE 25.NORTH AMERICA CELL CULTURE MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 26.NORTH AMERICA CELL CULTURE MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 27.NORTH AMERICA CELL CULTURE MARKET, BY END USER, 2019–2027($MILLION)
TABLE 28.EUROPE CELL CULTURE MARKET, BY COUNTRY, 2019–2027($MILLION)
TABLE 29.GERMANY CELL CULTURE MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 30.GERMANY CELL CULTURE MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 31.GERMANY CELL CULTURE MARKET, BY END USER, 2019–2027($MILLION)
TABLE 32.FRANCE CELL CULTURE MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 33.FRANCE CELL CULTURE MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 34.FRANCE CELL CULTURE MARKET, BY END USER, 2019–2027($MILLION)
TABLE 35.UK CELL CULTURE MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 36.UK CELL CULTURE MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 37.UK CELL CULTURE MARKET, BY END USER, 2019–2027($MILLION)
TABLE 38.ITALY CELL CULTURE MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 39.ITALY CELL CULTURE MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 40.ITALY CELL CULTURE MARKET, BY END USER, 2019–2027($MILLION)
TABLE 41.SPAIN CELL CULTURE MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 42.SPAIN CELL CULTURE MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 43.SPAIN CELL CULTURE MARKET, BY END USER, 2019–2027($MILLION)
TABLE 44.REST OF EUROPE CELL CULTURE MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 45.REST OF EUROPE CELL CULTURE MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 46.REST OF EUROPE CELL CULTURE MARKET, BY END USER, 2019–2027($MILLION)
TABLE 47.EUROPE CELL CULTURE MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 48.EUROPE CELL CULTURE MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 49.EUROPE CELL CULTURE MARKET, BY END USER, 2019–2027($MILLION)
TABLE 50.ASIA-PACIFIC CELL CULTURE MARKET, BY COUNTRY, 2019–2027($MILLION)
TABLE 51.JAPAN CELL CULTURE MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 52.CHINA CELL CULTURE MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 53.CHINA CELL CULTURE MARKET, BY END USER, 2019–2027($MILLION)
TABLE 54.JAPAN CELL CULTURE MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 55.JAPAN CELL CULTURE MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 56.CHINA CELL CULTURE MARKET, BY END USER, 2019–2027($MILLION)
TABLE 57.AUSTRALIA CELL CULTURE MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 58.AUSTRALIA CELL CULTURE MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 59.AUSTRALIA CELL CULTURE MARKET, BY END USER, 2019–2027($MILLION)
TABLE 60.INDIA CELL CULTURE MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 61.INDIA CELL CULTURE MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 62.INDIA CELL CULTURE MARKET, BY END USER, 2019–2027($MILLION)
TABLE 63.SOUTH KOREA CELL CULTURE MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 64.SOUTH KOREA CELL CULTURE MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 65.SOUTH KOREA CELL CULTURE MARKET, BY END USER, 2019–2027($MILLION)
TABLE 66.REST OF ASIA-PACIFIC CELL CULTURE MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 67.REST OF ASIA-PACIFIC CELL CULTURE MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 68.REST OF ASIA-PACIFIC CELL CULTURE MARKET, BY END USER, 2019–2027($MILLION)
TABLE 69.ASIA-PACIFIC CELL CULTURE MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 70.ASIA-PACIFIC CELL CULTURE MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 71.ASIA-PACIFIC CELL CULTURE MARKET, BY END USER, 2019–2027($MILLION)
TABLE 72.LAMEA CELL CULTURE MARKET, BY COUNTRY, 2019–2027($MILLION)
TABLE 73.BRAZIL CELL CULTURE MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 74.BRAZIL CELL CULTURE MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 75.BRAZIL CELL CULTURE MARKET, BY END USER, 2019–2027($MILLION)
TABLE 76.SAUDI ARABIA CELL CULTURE MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 77.SAUDI ARABIA CELL CULTURE MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 78.SAUDI ARABIA CELL CULTURE MARKET, BY END USER, 2019–2027($MILLION)
TABLE 79.SOUTH AFRICA CELL CULTURE MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 80.SOUTH AFRICA CELL CULTURE MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 81.SOUTH AFRICA CELL CULTURE MARKET, BY END USER, 2019–2027($MILLION)
TABLE 82.REST OF LAMEA CELL CULTURE MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 83.REST OF LAMEA CELL CULTURE MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 84.REST OF LAMEA CELL CULTURE MARKET, BY END USER, 2019–2027($MILLION)
TABLE 85.LAMEA CELL CULTURE MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 86.LAMEA CELL CULTURE MARKET, BY APPLICATION, 2019–2027($MILLION)
TABLE 87.LAMEA CELL CULTURE MARKET, BY END USER, 2019–2027($MILLION)
TABLE 88.BD: SNAPSHOT
TABLE 89.BD: OPERATING SEGMENTS
TABLE 90.BD: PRODUCT PORTFOLIO
TABLE 91.CORNING: COMPANY SNAPSHOT
TABLE 92.CORNING: OPERATING SEGMENT
TABLE 93.CORNING: PRODUCT PORTFOLIO
TABLE 94.CORNING: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 95.DANAHER: COMPANY SNAPSHOT
TABLE 96.DANAHER: OPERATING SEGMENTS
TABLE 97.DANAHER: PRODUCT PORTFOLIO
TABLE 98.EPPENDORF: COMPANY SNAPSHOT
TABLE 99.EPPENDORF: PRODUCT PORTFOLIO
TABLE 100.HIMEDIA: COMPANY SNAPSHOT
TABLE 101.HIMEDIA:OPERATING PRODUCT SEGMENT
TABLE 102.HIMEDIA: PRODUCT PORTFOLIO
TABLE 103.LONZA: COMPANY SNAPSHOT
TABLE 104.PRODUCT PORTFOLIO
TABLE 105.LONZA: PRODUCT PORTFOLIO
TABLE 106.LONZA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 107.MERCK: COMPANY SNAPSHOT
TABLE 108.MERCK: OPERATING SEGMENTS
TABLE 109.MERCK: PRODUCT PORTFOLIO
TABLE 110.MERCK: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 111.PROMOCELL: COMPANY SNAPSHOT
TABLE 112.PROMOCELL: PRODUCT PORTFOLIO
TABLE 113.SARTORIUS: COMPANY SNAPSHOT
TABLE 114.SARTORIUS: OPERATING BUSINESS SEGMENTS
TABLE 115.SARTORIUS: PRODUCT PORTFOLIO
TABLE 116.SARTORIUS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 117.THERMO FISHER: COMPANY SNAPSHOT
TABLE 118.THERMO FISHER.: OPERATING SEGMENTS
TABLE 119.THERMO FISHER.: PRODUCT PORTFOLIO
TABLE 120.THERMO FISHER: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 01.GLOBAL CELL CULTURE MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018–2020*
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2020* (%)
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018–2020*
FIGURE 06.HIGH BARGAINING POWER OF SUPPLIER
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.HIGH THREAT OF SUBSTITUTES
FIGURE 09.MODERATE INTENSITY OF RIVALRY
FIGURE 10.LOW THREAT OF NEW ENTRANT
FIGURE 11.MARKET SHARE ANALYSIS
FIGURE 12.IMPACT ANALYSES, CELL CULTURE MARKET
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF INSTRUMENTS CELL CULTURE MARKET BY COUNTRY,
2019 & 2027 (%)
FIGURE 14.BIOREACTORS IN CELL CULTURE MARKET, 2019 & 2027 ($MILLION)
FIGURE 15.CELL CULTURE VESSELS IN CELL CULTURE MARKET, 2019 & 2027 ($MILLION)
FIGURE 16.CELL CULTURE STORAGE EQUIPMENT IN CELL CULTURE MARKET, 2019 & 2027 ($MILLION)
FIGURE 17.CELL CULTURE SUPPORTING INSTRUMENTS IN CELL CULTURE MARKET, 2019 & 2027 ($MILLION)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF CONSUMABLES CELL CULTURE MARKET, BY COUNTRY,
2019 & 2027 (%)
FIGURE 19.SERA IN CELL CULTURE MARKET, 2019 & 2027 ($MILLION)
FIGURE 20.MEDIA IN CELL CULTURE MARKET, 2019 & 2027 ($MILLION)
FIGURE 21.REAGENTS IN CELL CULTURE MARKET, 2019 & 2027 ($MILLION)
FIGURE 22.BIOREACTOR ACCESSORIES IN CELL CULTURE MARKET, 2019 & 2027 ($MILLION)
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF CELL CULTURE MARKET FOR STEM CELL TECHNOLOGY,
BY COUNTRY, 2019 & 2027 (%)
FIGURE 24.COMPARATIVE SHARE ANALYSIS OF CELL CULTURE MARKET FOR CANCER RESEARCH, BY COUNTRY, 2019 & 2027 (%)
FIGURE 25.COMPARATIVE SHARE ANALYSIS OF CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2019 & 2027 (%)
FIGURE 26.COMPARATIVE SHARE ANALYSIS OF CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2019 & 2027 (%)
FIGURE 27.COMPARATIVE SHARE ANALYSIS OF CELL CULTURE MARKET FOR OTHERS, BY COUNTRY,
2019 & 2027 (%)
FIGURE 28.COMPARATIVE SHARE ANALYSIS OF CELL CULTURE MARKET FOR RESEARCH INSTITUTES,
BY COUNTRY, 2019 & 2027 (%)
FIGURE 29.COMPARATIVE SHARE ANALYSIS OF CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019 & 2027 (%)
FIGURE 30.COMPARATIVE SHARE ANALYSIS OF CELL CULTURE MARKET FOR OTHERS, BY COUNTRY,
2019 & 2027 (%)
FIGURE 31.CANCER INCIDENCES IN GERMANY (2007 & 2050)
FIGURE 32.BD: NET SALES, 2017–2019 ($MILLION)
FIGURE 33.BD: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 34.BD: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 35.CORNING: NET SALES, 2017–2019 ($MILLION)
FIGURE 36.CORNING: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 37.CORNING: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 38.DANAHER: NET SALES, 2017–2019 ($MILLION)
FIGURE 39.DANAHER: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 40.DANAHER: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 41.EPPENDORF: NET SALES, 2017–2019 ($MILLION)
FIGURE 42.EPPENDORF: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 43.LONZA: NET SALES, 2017–2019 ($MILLION)
FIGURE 44.LONZA: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 45.MERCK: NET SALES, 2017–2019 ($MILLION)
FIGURE 46.MERCK: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 47.MERCK: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 48.SARTORIUS: NET SALES, 2017–2019 ($MILLION)
FIGURE 49.SARTORIUS: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 50.SARTORIUS: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 51.THERMO FISHER: NET SALES, 2017–2019 ($MILLION)
FIGURE 52.THERMO FISHER: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 53.THERMO FISHER: REVENUE SHARE, BY REGION, 2019 (%)
